A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary purpose of this study is to evaluate the abuse potential of lemborexant (E2006) in comparison to placebo and 2 controls with known abuse potential (ie, zolpidem and suvorexant) with similar indications (zolpidem and suvorexant) or mechanisms of action (suvorexant).
Epistemonikos ID: a559301503dd803bbb75d8b3a6c6da8f81b433a1
First added on: May 20, 2024